# Opus Genetics, Inc.: Form 8-K, filed Jul 1, 2020

- Company: [Opus Genetics, Inc.](/companies/ird.md) (CIK 1228627)
- Form: 8-K
- Filed: 2020-07-01
- Accepted by EDGAR: Jul 1, 2020, 08:37 ET
- Period: 2020-06-29
- Accession: 0001140361-20-015244
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1228627/000114036120015244/nt10013045x2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1228627/000114036120015244/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1228627/000114036120015244/nt10013045x2_8k.htm

Filed Jul 1, 2020.
Source: SEC EDGAR, the filing index for accession 0001140361-20-015244. Last ingested by Listed: Nov 12, 2026, 19:22 ET. No prices; not investment advice.
